Figure 3.

Voltage dependence of Cav2.1 (α1A-2) and stably expressed Cav2.3c channel inhibition via GABABR activation. (A) I-V relationships in Cav2.1/GABABR cells (left) in the absence (control) and presence of 50 µM baclofen, and in Cav2.3/GABABR cells (right) in the absence (control) or presence of 50 µM baclofen or 200 nM c-Vc1.1. (Insets) Voltage protocol and representative normalized current traces (only 23 ms of the 100-ms traces are shown). See Table S1 for V0.5,act values. (B) Cav2.1 channel inhibition via GABABR is VD, whereas that of Cav2.3c is VI. Representative 15-mV depolarization-activated inward IBa from Cav2.1/GABABR cells (top) in the absence (control) or presence of 50 µM baclofen, without (−PP) or after the application of a depolarizing prepulse to +80 mV (+PP). (Bottom) Representative 10-mV depolarization-activated IBa from Cav2.3/GABABR cells in the absence (control) or presence of 50 µM baclofen or 200 nM c-Vc1.1. Dotted lines indicate zero-current level. The voltage protocol (top inset) is described in Materials and methods. (Right) Summary of IBa inhibition in the absence or presence of a prepulse. Data are mean ± SEM (paired Student’s t test; *, P < 0.001 vs. control [−PP] in Cav2.1/GABABR cells). The number of experiments is in parentheses. VD, voltage dependent; VI, voltage independent.

or Create an Account

Close Modal
Close Modal